Cargando…

HMGB1 in nervous system diseases: A common biomarker and potential therapeutic target

High-mobility group box-1 (HMGB1) is a nuclear protein associated with early inflammatory changes upon extracellular secretion expressed in various cells, including neurons and microglia. With the progress of research, neuroinflammation is believed to be involved in the pathogenesis of neurological...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Di, Zheng, Yuan, Xu, Fenfen, Han, Xiao, Zhao, Hongyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659947/ https://www.ncbi.nlm.nih.gov/pubmed/36388178 http://dx.doi.org/10.3389/fneur.2022.1029891

Ejemplares similares

Advances in the study of IL-17 in neurological diseases and mental disorders
por: Lu, Yu, et al.
Publicado: (2023)

Biomarkers in Vasculitides of the Nervous System
por: Strunk, Daniel, et al.
Publicado: (2019)

Trimethylamine-N-oxide: a potential biomarker and therapeutic target in ischemic stroke
por: Liu, Yuan, et al.
Publicado: (2023)

A Brief Overview on BDNF-Trk Pathway in the Nervous System: A Potential Biomarker or Possible Target in Treatment of Multiple Sclerosis?
por: Schirò, Giuseppe, et al.
Publicado: (2022)

HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma
por: Wang, Yanbin, et al.
Publicado: (2019)

Bioinformatic identification of potential biomarkers and therapeutic targets in carotid atherosclerosis and vascular dementia
por: Li, Dongshi, et al.
Publicado: (2023)

Primary Angiitis of the Central Nervous System: New Potential Imaging Techniques and Biomarkers in Blood and Cerebrospinal Fluid
por: Deb-Chatterji, Milani, et al.
Publicado: (2019)

HMGB1 as a potential biomarker and therapeutic target for severe COVID-19
por: Chen, Ruochan, et al.
Publicado: (2020)

Emerging Roles of microRNAs as Biomarkers and Therapeutic Targets for Diabetic Neuropathy
por: Fan, Baoyan, et al.
Publicado: (2020)

HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction
por: Paudel, Yam Nath, et al.
Publicado: (2018)

Endocannabinoid system components as potential neuroimmune therapeutic targets in tinnitus
por: Bhat, Vishweshwara, et al.
Publicado: (2023)

Therapeutic potential of HMGB1-targeting agents in sepsis
por: Wang, Haichao, et al.
Publicado: (2008)

Bacteria commonly associated with central nervous system catheter infections elicit distinct CSF proteome signatures
por: Beaver, Matthew, et al.
Publicado: (2023)

The Potential Role of Hypoxia-Inducible Factor-1 in the Progression and Therapy of Central Nervous System Diseases
por: Chen, Hongxiu, et al.
Publicado: (2022)

Bioinformatics analysis to identify potential biomarkers and therapeutic targets for ST-segment–elevation myocardial infarction-related ischemic stroke
por: Feng, Shuo, et al.
Publicado: (2022)

Editorial: Anesthetic neurotoxicity in developing brains: mechanisms, biomarkers, and therapeutic targets
por: Yu, Yang, et al.
Publicado: (2023)

Circulating Endothelial Cells as Promising Biomarkers in the Differential Diagnosis of Primary Angiitis of the Central Nervous System
por: Deb-Chatterji, Milani, et al.
Publicado: (2020)

Advanced central nervous system imaging biomarkers in radiologically isolated syndrome: a mini review
por: Collorone, Sara, et al.
Publicado: (2023)

HMGB3 is a Potential Therapeutic Target by Affecting the Migration and Proliferation of Colorectal Cancer
por: Gong, Wenjing, et al.
Publicado: (2022)

Podoplanin: A potential therapeutic target for thrombotic diseases
por: Huang, Yaqian, et al.
Publicado: (2023)

Targeting HMGB1: A Potential Therapeutic Strategy for Chronic Kidney Disease
por: Liu, Tongtong, et al.
Publicado: (2023)

The Role of Caspase Family in Acute Brain Injury: The Potential Therapeutic Targets in the Future
por: Zhang, Anke, et al.
Publicado: (2022)

Is Mossy Fiber Sprouting a Potential Therapeutic Target for Epilepsy?
por: Cavarsan, Clarissa F., et al.
Publicado: (2018)

Glial Cells in Glaucoma: Friends, Foes, and Potential Therapeutic Targets
por: García-Bermúdez, Mariana Y., et al.
Publicado: (2021)

Potential Goals, Challenges, and Safety of Focused Ultrasound Application for Central Nervous System Disorders
por: Pérez-Neri, Iván, et al.
Publicado: (2022)

HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases
por: Ren, Wenxuan, et al.
Publicado: (2023)

Primary Central Nervous System Lymphomatoid Granulomatosis: Systemic Review
por: Xiang, Yuanyuan, et al.
Publicado: (2020)

Intravascular lymphoma of the central nervous system: a rare subtype of a common disease
por: de CARVALHO, Ruann Melo, et al.
Publicado: (2021)

Potential Roles of α-amylase in Alzheimer’s Disease: Biomarker and Drug Target
por: Chen, Win Ning, et al.
Publicado: (2022)

CXCL13 and CXCL9 CSF Levels in Central Nervous System Lymphoma—Diagnostic, Therapeutic, and Prognostic Relevance
por: Masouris, Ilias, et al.
Publicado: (2021)

Transcranial low-intensity ultrasound stimulation for treating central nervous system disorders: A promising therapeutic application
por: Hu, Yun-Yun, et al.
Publicado: (2023)

Therapeutic Potential of Targeting the HMGB1/RAGE Axis in Inflammatory Diseases
por: Singh, Harbinder, et al.
Publicado: (2022)

Exosomal microRNAs as Potential Biomarkers and Therapeutic Agents for Acute Ischemic Stroke: New Expectations
por: Xu, Yingzhi, et al.
Publicado: (2022)

Non-Coding RNAs: Emerging Therapeutic Targets in Spinal Cord Ischemia–Reperfusion Injury
por: Ling, Xiao, et al.
Publicado: (2021)

Editorial: Potential biomarkers in neurovascular disorders
por: Xu, Yuzhen, et al.
Publicado: (2023)

Circulating microRNAs as potential biomarkers and therapeutic targets in spinal muscular atrophy
por: Chen, Tai-Heng
Publicado: (2020)

Coronaviruses and Central Nervous System Manifestations
por: Khateb, Mohamed, et al.
Publicado: (2020)

Architecture of the Cutaneous Autonomic Nervous System
por: Glatte, Patrick, et al.
Publicado: (2019)

Longitudinal changes in the hypothalamic–pituitary–adrenal axis and sympathetic nervous system are related to the prognosis of stroke
por: Chen, Xu-Guang, et al.
Publicado: (2022)

The Role of High Mobility Group Box 1 (HMGB1) in Neurodegeneration: A Systematic Review
por: Ikram, Fathimath Zaha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9sq2c91vcvucnnu6jhsmb9pms1